Volv Global personalises healthcare by providing insights on patients and diseases powered by data-driven AI and machine learning.
Our custom, proprietary, machine learning algorithms power a suite of services for pharmaceutical companies that reduces costs throughout the healthcare ecosystem and improves outcomes for those living with disease.
Stratify and triage patients for individualised and optimised treatment, saving time, cost and the emotional burden of incorrect diagnosis.
Characterise, segment and target patient cohorts to make clinical development and commercialisation more efficient and cost-effective.
Generate novel insights and new understanding of patient biomarkers, phenotypes, clinical features and endpoints.
Optimise resource allocation and reduce cost impact of incorrect or late diagnoses, while maximising quality of life and outcomes.
Volv Global helps you work smarter
Volv Global uses AI and population-scale data to generate knowledge and insights into difficult-to-diagnose diseases that others cannot match. Our clients can leverage these insights to enhance clinical development strategies, enrich disease understanding, and gain an edge over their rivals. Our insights help identify opportunities to rapidly develop diagnostic tools, reposition existing drugs that increase R&D viability, so our clients can target new markets, work smarter and drive profitability.
Volv Global delivers high-value solutions at speed
De-risk clinical strategy & improve robustness of trial planning.
Generate meaningful and valuable real-world evidence.
Expand the boundaries of medical understanding with new RWD insights.
Launch strongly and extend the product lifecycle by finding more patients.
Introducing inTrigue
With inTrigue, our flagship machine learning methodology, Volv Global transforms disease management and treatment at the individual patient level, along the patient journey and optimising patient outcomes.
Understanding patient phenomenology, across all diseases.
We ensure that all patients are offered the right treatment options and increase the pool of RWD on a disease.
We detect subtle patterns among biomarkers to predict disease incidence early, sometimes years ahead of time.
We model disease progression and are able to provide prognoses, instead of diagnoses.
We detect, cluster and differentiate sub-groups within a heterogenous patient cohort, to learn more about disease pathways.
The human story
Volv Global helps transform lives by giving pharmaceutical innovators powerful insights into difficult-to-diagnose diseases so they can develop effective tools and treatments. To the patient this might look like earlier diagnosis, a lifechanging drug or the opportunity to connect with a wider community for education and support as they navigate life with a rare disease.
Stay informed
Go deeper
Stay informed
Go deeper
Ready to shape the future of healthcare? Let’s explore how our machine learning solutions can accelerate diagnoses, refine patient journeys, and drive meaningful impact for those who need it most. We value your ideas and expertise, reach out now to unlock new possibilities together.
